Hepatitis C
📧 Sign up to get email alerts when something new happens for Hepatitis C.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2016-03-04Clinical Trial Update: A Study of Different Durations of Treatment With Grazoprevir (MK-5172) in Combination With Ribavirin in Participants With Chronic Hepatitis C (MK-5172-039) [Phase 2]
Phase 2 trial evaluating different durations of Grazoprevir (MK-5172) with Ribavirin in chronic Hepatitis C patients; results posted after c…
-
CLINICAL_TRIALS trial_result · 2016-03-04Clinical Trial Update: Efficacy and Safety of Combination Grazoprevir (MK-5172) + Elbasvir (MK-8742) + Ribavirin (RBV) in Genotype 2 Hepatitis C Infection (MK-5172-047) [Phase 2]
Phase 2 trial assessing the efficacy and safety of a Grazoprevir/Elbasvir plus Ribavirin regimen in genotype 2 Hepatitis C infection; comple…
-
CLINICAL_TRIALS trial_result · 2016-03-04Clinical Trial Update: A Study of PEGASYS (Peginterferon Alfa-2a (40KD)) in Combination With Copegus (Ribavirin) in Patients With Chronic Hepatitis C (CHC) Enrolled in a Methadone Maintenance Treatment Program. [Phase 4]
This Phase 4 clinical trial update reports completion and posted results for the combination of peginterferon alfa-2a and ribavirin in patie…
-
CLINICAL_TRIALS trial_result · 2016-03-04Clinical Trial Update: Ledipasvir/Sofosbuvir Fixed-Dose Combination and Vedroprevir With or Without Ribavirin in Treatment-Experienced Participants With Chronic Genotype 1 HCV Infection and Cirrhosis [Phase 2]
Phase 2 trial evaluating fixed-dose Ledipasvir/Sofosbuvir with or without Vedroprevir (with or without ribavirin) in treatment-experienced c…
-
CLINICAL_TRIALS trial_result · 2016-03-04Clinical Trial Update: A Multiple Dose Study of Grazoprevir (MK-5172) in Hepatitis C-Infected Participants (MK-5172-010) [Phase 1]
Phase 1 multiple-dose study of Grazoprevir (MK-5172) in hepatitis C-infected participants has completed with results posted.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2016-03-04Clinical Trial Update: The Pharmacokinetics of Grazoprevir (MK-5172) and Elbasvir (MK-8742) in Participants With Renal Insufficiency (MK-5172-050) [Phase 1]
Phase 1 pharmacokinetic study evaluating grazoprevir and elbasvir in participants with renal impairment.
-
CLINICAL_TRIALS trial_result · 2016-03-04Clinical Trial Update: A Study of Different Doses of Grazoprevir (MK-5172) Given With Pegylated Interferon Alfa-2b and Ribavirin to Treatment-Naïve Participants With Chronic Hepatitis C (MK-5172-038) [Phase 2]
Phase 2 trial evaluating different doses of grazoprevir with pegylated interferon alfa-2b and ribavirin in treatment-naïve chronic hepatitis…
-
CLINICAL_TRIALS trial_result · 2016-03-04Clinical Trial Update: The SIM-SOF Trial for Hepatitis C [Phase 4]
This Phase 4 clinical trial update reports that the SIM-SOF trial in chronic hepatitis C has completed and results were posted.
-
CLINICAL_TRIALS trial_result · 2016-03-04Clinical Trial Update: Study to Investigate the Influence of Hepatic Insufficiency on the Pharmacokinetics of Grazoprevir (MK-5172-013) [Phase 1]
Phase 1 study assessing how hepatic insufficiency affects pharmacokinetics of Grazoprevir (MK-5172-013) in Hepatitis C patients; completed w…
-
CLINICAL_TRIALS trial_result · 2016-03-02Clinical Trial Update: Grazoprevir (MK-5172) Administered With Peginterferon and Ribavirin in Treatment-Naïve Participants With Chronic Hepatitis C (MK-5172-003) [Phase 2]
This entry reports the completion of a Phase 2 trial (MK-5172-003) evaluating Grazoprevir in combination with Peginterferon and Ribavirin in…
-
CLINICAL_TRIALS trial_result · 2016-03-02Clinical Trial Update: A Prospective Study to Evaluate the Specificity of the Cobas TaqScreen MPX Test for Use on the Cobas s 201 System for Screening Plasma Pools From Source Plasma Donors for the Presence of HBV DNA, HCV RNA, and HIV-1 RNA [NA]
A prospective study evaluating the specificity of Roche's Cobas TaqScreen MPX test for detecting HBV DNA, HCV RNA, and HIV-1 RNA in plasma p…
-
CLINICAL_TRIALS trial_result · 2016-03-02Clinical Trial Update: A Study of Grazoprevir (MK-5172) in Hepatitis C-Infected Male Participants (MK-5172-004) [Phase 1]
A Phase 1 study evaluating grazoprevir (MK-5172) in hepatitis C-infected male participants has completed, with results posted in 2016.
-
CLINICAL_TRIALS trial_result · 2016-03-02Clinical Trial Update: Peginterferon Plus Ribavirin Combination Therapy for Hepatitis C Six Months After Onset of Acute Infection [Phase 4]
Phase 4 clinical trial evaluating pegylated interferon plus ribavirin for acute hepatitis C when started about six months after infection. T…
-
CLINICAL_TRIALS trial_result · 2016-03-01Clinical Trial Update: Triple DAAs Regimen in Treating Non-cirrhotic HCV GT1b Subjects [Phase 2]
Phase 2 trial update on a triple direct-acting antiviral regimen for non-cirrhotic hepatitis C genotype 1b patients and the study status ind…
-
CLINICAL_TRIALS trial_result · 2016-02-24Clinical Trial Update: Simeprevir in Combination With Sofosbuvir in Treatment-Naïve or -Experienced Adults With Chronic Genotype 4 Hepatitis C Virus Infection [Phase 2]
Phase 2 trial evaluating the combination of simeprevir and sofosbuvir in treatment-naïve or experienced adults with chronic genotype 4 hepat…
-
CLINICAL_TRIALS trial_result · 2016-02-24Clinical Trial Update: Sofosbuvir and Ribavirin in Patients With Chronic HCV With Cirrhosis and Portal Hypertension With or Without Liver Decompensation [Phase 2]
Phase 2 trial evaluating sofosbuvir and ribavirin in adults with chronic hepatitis C and cirrhosis, including patients with portal hypertens…
-
CLINICAL_TRIALS trial_result · 2016-02-24Clinical Trial Update: Randomized Controlled Open Label Trial of Peg Alpha 2a Interferon and Adjusted-dose of Ribavirin vs. Standard Therapy in the Treatment of Naive Chronic Hepatitis C Patients Infected With Genotype 4 [Phase 4]
This is a Phase 4 randomized, open-label trial comparing pegylated interferon alfa-2a with adjusted-dose ribavirin to standard therapy in tr…
-
CLINICAL_TRIALS trial_result · 2016-02-24Clinical Trial Update: HCV/HIV Coinfection: Antiviral Therapy and Fibrosis
A completed Johns Hopkins University clinical trial studied antiviral therapy for HIV and Hepatitis C coinfection with a focus on liver fibr…
-
CLINICAL_TRIALS trial_result · 2016-02-24Clinical Trial Update: Response Modifier (Arabinoxylan Rice Bran/MGN-3/Biobran) With Interferon-Alpha for HCV [Phase 2]
A Phase 2 clinical trial conducted at Cairo University evaluating Biobran MGN-3 (arabinoxylan rice bran) in combination with Interferon-Alph…
-
CLINICAL_TRIALS trial_result · 2016-02-23Clinical Trial Update: Efficacy and Safety of Short Course Therapy With Peginterferon Alpha-2b (PEG-IFN Alfa-2b) and Ribavirin (RBV) for Chronic Hepatitis C (Genotype 4) Participants Achieving a Rapid Virological Response at Week 4 of Treatment (MK-8908B-059) [Phase 4]
Phase 4 trial evaluating short course peginterferon alfa-2b plus ribavirin in chronic hepatitis C genotype 4 patients who achieved rapid vir…
-
CLINICAL_TRIALS trial_result · 2016-02-22Clinical Trial Update: A Study to Evaluate the Efficacy and Safety of Three Experimental Drugs Compared With Telaprevir (a Licensed Product) in People With Hepatitis C Virus Infection Who Have Not Had Treatment Before [Phase 3]
A Phase 3 trial evaluating the efficacy and safety of three experimental hepatitis C therapies compared with Telaprevir in treatment-naive a…
-
CLINICAL_TRIALS trial_result · 2016-02-22Clinical Trial Update: An Observational Study of Peginterferon (e.g. Pegasys)-Based Direct Acting Antiviral Triple Therapy in Patients With Chronic Hepatitis C Genotype 1
An observational study evaluating peginterferon-based triple therapy for chronic hepatitis C genotype 1; the study is completed and results …
-
CLINICAL_TRIALS trial_result · 2016-02-18Clinical Trial Update: Risk of Post Transfusion Hepatitis C Virus Infection
A completed NHLBI clinical trial assesses the risk of hepatitis C virus infection after blood transfusion.
-
CLINICAL_TRIALS trial_result · 2016-02-17Clinical Trial Update: A Study of Debio 025 (Alisporivir) Combined With Peg-IFNα2a and Ribavirin in Treatment naïve Chronic Hepatitis C Genotype 1 Patients [NA]
A completed study evaluating the combination of alisporivir (Debio 025) with pegylated interferon alfa-2a and ribavirin in treatment-naïve p…
-
CLINICAL_TRIALS trial_result · 2016-02-15Clinical Trial Update: A Study of the Effectiveness of Peginterferon Alfa-2a (Pegasys) and Ribavirin Treatment in Slovenian Hepatitis C (HCV) Patients
A completed clinical trial in Slovenian patients with chronic hepatitis C evaluating peginterferon alfa-2a (Pegasys) in combination with rib…